Literature DB >> 7990976

Hypoxia induces release of atrial natriuretic peptide in rat atrial tissue: a role for this peptide during low oxygen stress.

M E Ljusegren1, R G Andersson.   

Abstract

A variety of different factors have been shown to induce release of atrial natriuretic peptide from atrial tissue. Among these, stretching of atrial myocytes is considered the most important. In a recent study we showed that atrial natriuretic peptide increased cGMP and reduced lactate accumulation during hypoxia in rat ventricular myocardium. This suggests that atrial natriuretic peptide has a beneficial metabolic effect during hypoxia and raises the question whether hypoxia alone induces release of atrial natriuretic peptide. The right atrium and pieces of the right ventricle, from rats, were incubated in polyethylene vials containing 3 ml Krebs bicarbonate buffer equilibrated with 75% N2 + 20% O2 + 5% CO2 (= hypoxic conditions) or 95% O2 + 5% CO2 (= normoxic conditions). After 10 min, the ventricular tissues and aliquots of the buffer were frozen. Cyclic GMP was analyzed in the ventricular tissue and atrial natriuretic peptide was analyzed in the buffer samples. The results show that the release of atrial natriuretic peptide during hypoxia significantly exceeds the release under normoxic conditions. The hypoxia-induced release of atrial natriuretic peptide over time is characterized by an s-shaped curve with the steepest slope after about 10 min. In the presence of atrial tissue the intracellular level of cGMP in ventricular myocardium increased from 0.3 +/- 0.1 to 2.6 +/- 0.9 pmol/g w wt (P = 0.033, n = 6). We conclude that ANP is released from atrial tissue and induces increased formation of cGMP in ventricular myocardium when oxygen tension is low.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7990976     DOI: 10.1007/BF00241095

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  32 in total

1.  Transient acute myocardial ischemia increases atrial natriuretic peptide release in men.

Authors:  P De Marzio; S Morelli; C Ferri; M Cacciafesta; C Bellini; A Perrone; F Aguglia; A Santucci; F Balsano
Journal:  J Hypertens Suppl       Date:  1991-12

2.  Characterisation of atrial natriuretic peptide receptors in bovine ventricular sarcolemma.

Authors:  S McCartney; J F Aiton; G Cramb
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

Review 3.  Atrial natriuretic peptide: its mechanism of release from the atrium.

Authors:  R Ferrari; G Agnoletti
Journal:  Int J Cardiol       Date:  1989       Impact factor: 4.164

4.  Evidence for alpha-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart.

Authors:  M G Currie; W H Newman
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

5.  Atriopeptin III induces early relaxation of isolated mammalian papillary muscle.

Authors:  A L Meulemans; K R Sipido; S U Sys; D L Brutsaert
Journal:  Circ Res       Date:  1988-06       Impact factor: 17.367

6.  Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease.

Authors:  Y Hirata; M Ishii; H Matsuoka; T Sugimoto; M Iizuka; Y Uchida; T Serizawa; H Sato; O Kohmoto; T Mochizuki
Journal:  Am Heart J       Date:  1987-06       Impact factor: 4.749

7.  In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.

Authors:  C L Huang; H E Ives; M G Cogan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Local release of myocardial norepinephrine during acute ischemia: an experimental study in the isolated perfused rat heart.

Authors:  L Carlsson; T Abrahamsson; O Almgren
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

Review 9.  Atrial natriuretic peptide in man.

Authors:  P Weidmann; H Saxenhofer; S G Shaw; C Ferrier
Journal:  J Steroid Biochem       Date:  1989-01       Impact factor: 4.292

10.  Sodium nitroprusside inhibits lactate formation in rat atria: is cyclic GMP involved?

Authors:  K Laustiola; P Vuorinen; H Vapaatalo; T Metsä-Ketelä
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1983-03
View more
  5 in total

1.  Hypoxia regulates the natriuretic peptide system.

Authors:  Olli Arjamaa; Mikko Nikinmaa
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-07

2.  Brain natriuretic peptide and acute hypobaric hypoxia in humans.

Authors:  David Woods; Tim Hooper; Adrian Mellor; Pete Hodkinson; Rob Wakeford; Bob Peaston; Steve Ball; Nic Green
Journal:  J Physiol Sci       Date:  2011-03-24       Impact factor: 2.781

3.  Hypoxia increases the release of salmon cardiac peptide (sCP) from the heart of rainbow trout (Oncorhynchus mykiss) under constant mechanical load in vitro.

Authors:  Olli Arjamaa; Olli Vuolteenaho; Elina Kivi; Mikko Nikinmaa
Journal:  Fish Physiol Biochem       Date:  2013-06-29       Impact factor: 2.794

4.  Atrial natriuretic peptide infusion and nitric oxide inhalation in patients with acute respiratory distress syndrome.

Authors:  A J Bindels; J G van der Hoeven; P H Groeneveld; M Frölich; A E Meinders
Journal:  Crit Care       Date:  2001-04-20       Impact factor: 9.097

5.  Hypoxia exposure and B-type natriuretic peptide release from Langendorff heart of rats.

Authors:  K Anttila; T Streng; J Pispa; M Vainio; M Nikinmaa
Journal:  Acta Physiol (Oxf)       Date:  2016-08-26       Impact factor: 6.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.